- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Neurocrine Biosciences Inc+ Add to Watchlist
NB3:GR6.855 EUR 0.172 2.45%
As of 02:08:30 ET on 12/11/2013.
Company Profile for Neurocrine Biosciences Inc (NB3)
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
Neurocrine Biosciences Inc
Key Executives for Neurocrine Biosciences Inc (NB3)
|Kevin C GormanPresident/CEO||Timothy P CoughlinChief Financial Officer|
|Christopher F O'BrienChief Medical Officer||Haig P BozigianChief Development Officer|
|Dimitri E GrigoriadisChief Research Officer|